Evidence-based·Updated November 20, 2026·How we grade evidence

Bupropion

MedicationAntidepressant and smoking cessation aid (prescription)

Bupropion is an established antidepressant and smoking-cessation aid. A network meta-analysis found all 21 antidepressants studied, including bupropion, better than placebo for adult depression. Three trials in 1,042 people with seasonal affective disorder found fewer winter depressions when bupropion XL was started in autumn. A Cochrane review rated the evidence high-certainty that bupropion increases long-term quit rates (risk ratio 1.60), though it is less effective than varenicline. St. John's wort is the moderate supplement interaction; alcohol is critical (seizure risk, including when heavy drinking stops suddenly) and nicotine replacement is moderate (blood pressure checks); seizure risk and MAO inhibitors are the main label cautions.

Taking Bupropion with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with major depressive disorder, adults with a history of autumn-winter seasonal depression (Wellbutrin XL, Aplenzin), and adults who want medicine to help quit smoking (bupropion SR), with a prescriber

Common dosing range

Set by your prescriber. Wellbutrin XL: 150 mg once daily in the morning, then usually 300 mg once daily. Wellbutrin SR: 150 mg once daily, then 150 mg twice daily at least 8 hours apart (maximum 400 mg a day). Smoking cessation (bupropion SR): 150 mg a day for 3 days, then 150 mg twice daily, not more than 300 mg a day, for 7 to 12 weeks

When to expect effects

Depression trials lasted 4 to 6 weeks; seasonal trials ran from autumn to spring; smoking trials measured quitting after at least 6 months

Watch out for

Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Can cause seizures: not for people with a seizure disorder, an eating disorder, or who are suddenly stopping alcohol or sedatives. Can raise blood pressure. Never combine with MAO inhibitors. Keep alcohol to a minimum or avoid it

What is it

Bupropion is a prescription antidepressant of the aminoketone class, sold as generic tablets in immediate-release, sustained-release (SR) and extended-release (XL) forms, and as Wellbutrin SR, Wellbutrin XL, Aplenzin (bupropion hydrobromide) and Forfivo XL (450 mg). The Wellbutrin XL and Aplenzin labels approve it for major depressive disorder and for preventing seasonal depressive episodes in seasonal affective disorder; Wellbutrin SR and Forfivo XL are approved for major depressive disorder. Bupropion is also approved as an aid to quitting smoking. The Wellbutrin labels say Wellbutrin itself is not approved for that use but contains the same active ingredient as Zyban, which is; Zyban has no current DailyMed listing, so this page uses a generic bupropion SR label that is approved for smoking cessation. Unlike most antidepressants it does not block serotonin reuptake. Its boxed warning covers suicidal thoughts and behaviors in young people. For supplements, St. John's wort is the moderate-severity interaction on this page and saffron a low-severity one.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have major depressive disorder and your prescriber recommends bupropion (with a prescriber)
You have a pattern of autumn-winter depression and your prescriber recommends starting bupropion XL in autumn (with a prescriber)
You want to quit smoking and your prescriber recommends bupropion SR as part of a quit plan with counseling (with a prescriber)

Probably skip if…

You have a seizure disorder, or a current or past diagnosis of bulimia or anorexia nervosa (contraindicated)
You are suddenly stopping alcohol, benzodiazepines, barbiturates or antiseizure drugs (contraindicated)
You take an MAO inhibitor or stopped one in the last 14 days, or are being treated with linezolid or intravenous methylene blue (contraindicated)
You already take another bupropion product, such as one for smoking or depression: they should not be combined
You want to keep taking St. John's wort without telling your prescriber

Evidence at a glance

smoking cessation

Strong Evidence
Effect
Moderate; about 60% more people quit than with placebo
Best fit
Adults who smoke and want to quit, combined with counseling
Time
Quitting measured after at least 6 months; treatment usually 7 to 12 weeks

major depressive disorder in adults

Good Evidence
Effect
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Time
Acute treatment trials lasting weeks

prevention of seasonal affective disorder (autumn-winter depression)

Good Evidence
Effect
Moderate; 44% relative reduction in seasonal depressive episodes
Best fit
Adults with a history of autumn-winter seasonal major depression, starting treatment in autumn before symptoms
Time
Over one autumn-to-spring season

smoking cessation in people with and without psychiatric disorders

Good Evidence
Effect
Moderate; odds of abstinence about twice placebo
Best fit
Motivated adult smokers, including those with stable psychiatric conditions
Time
Measured at weeks 9 to 12

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

smoking cessation

Disease adjunct
Strong Evidence

A 2023 Cochrane review of 124 studies found high-certainty evidence that bupropion increased long-term quit rates compared with placebo or no medicine (risk ratio 1.60, 95% CI 1.49 to 1.72; 50 studies, 18,577 people), with quitting measured after at least 6 months. Bupropion was less effective than varenicline (risk ratio 0.73) and combination nicotine replacement, and similar to single-form nicotine replacement. It caused more dropouts due to side effects than placebo (risk ratio 1.44, high certainty), and may increase serious adverse events (risk ratio 1.16, 95% CI 0.90 to 1.48, moderate certainty).

Effect size
Moderate; about 60% more people quit than with placebo
Time to effect
Quitting measured after at least 6 months; treatment usually 7 to 12 weeks
Best fit
Adults who smoke and want to quit, combined with counseling
Less likely
People for whom varenicline or combination nicotine replacement is suitable, since those worked better

Bottom line: Bupropion reliably helps people quit smoking, though varenicline and combination nicotine replacement work better.

major depressive disorder in adults

Disease adjunct
Good Evidence

A 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied, including bupropion, were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. The authors rated the certainty of evidence moderate to very low. Trials with many people with bipolar, psychotic or treatment-resistant depression were excluded. The Wellbutrin XL label also cites a placebo-controlled withdrawal trial in which people who kept taking bupropion SR after responding had fewer relapses over 44 weeks.

Effect size
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Time to effect
Acute treatment trials lasting weeks
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Less likely
Children and teens, and people with bipolar depression, for which bupropion is not approved

Bottom line: Bupropion works better than placebo for adult depression.

prevention of seasonal affective disorder (autumn-winter depression)

Disease adjunct
Good Evidence

Three randomized, placebo-controlled prevention trials enrolled 1,042 adults with seasonal affective disorder across the northern US and Canada while they were still well in autumn, and treated them with bupropion XL 150 to 300 mg a day or placebo until spring. Major depression came back in 19% versus 30%, 13% versus 21%, and 16% versus 31% in the three trials, a relative risk reduction of 44% overall. Almost 60% had never been treated for depression before, despite an average of 13 past seasonal episodes.

Effect size
Moderate; 44% relative reduction in seasonal depressive episodes
Time to effect
Over one autumn-to-spring season
Best fit
Adults with a history of autumn-winter seasonal major depression, starting treatment in autumn before symptoms
Less likely
People with depression without a seasonal pattern, who were not studied in these trials

Bottom line: Starting bupropion XL in autumn reduced winter depressive episodes by 44% compared with placebo.

smoking cessation in people with and without psychiatric disorders

Disease adjunct
Good Evidence

The EAGLES trial randomized 8,144 smokers, half with a psychiatric disorder, at 140 centers in 16 countries to bupropion 150 mg twice daily, varenicline, nicotine patch or placebo for 12 weeks. Bupropion did not significantly increase moderate or severe neuropsychiatric side effects compared with placebo or the patch: 2.2% versus 2.4% on placebo in people without psychiatric disorders, and 6.7% versus 4.9% in those with them (a difference that was not statistically significant). Bupropion raised continuous abstinence in weeks 9 to 12 compared with placebo (odds ratio 2.07) but less than varenicline. The trial was funded by the drug makers.

Effect size
Moderate; odds of abstinence about twice placebo
Time to effect
Measured at weeks 9 to 12
Best fit
Motivated adult smokers, including those with stable psychiatric conditions
Less likely
People needing long-term data beyond 24 weeks, which this trial did not provide

Bottom line: In a large trial, bupropion helped smokers quit without a significant rise in serious psychiatric side effects, though varenicline worked better.

How it works

The label says the way bupropion works is unknown but is presumed to involve norepinephrine and dopamine: it is a relatively weak blocker of their reuptake and does not inhibit monoamine oxidase or serotonin reuptake. The liver turns it into active metabolites, mainly hydroxybupropion through the enzyme CYP2B6. The Wellbutrin XL label gives a mean half-life of 21 hours, with steady levels in about 8 days. These features shape its interactions. Bupropion can cause seizures, and the risk rises with dose, with other drugs that lower the seizure threshold, and with heavy alcohol use or sudden stopping of alcohol, benzodiazepines or barbiturates. Bupropion and its metabolites block CYP2D6, so they can raise levels of drugs cleared by that enzyme (some antidepressants, antipsychotics, metoprolol), and the label says that in theory tamoxifen, which needs CYP2D6 to work, could be less effective. Drugs and herbs that speed up its metabolism, such as St. John's wort, can lower bupropion levels. With MAO inhibitors there is a risk of dangerous blood pressure rises.

How to take it

1. Typical dose
Your prescriber sets the dose. Wellbutrin XL for depression starts at 150 mg once daily in the morning; after 4 days the dose may go to the usual target of 300 mg once daily. For seasonal affective disorder it starts at 150 mg and may rise to 300 mg after 7 days. Wellbutrin SR starts at 150 mg once daily in the morning; after 3 days it may rise to 150 mg twice daily, with at least 8 hours between doses, and a maximum of 400 mg a day (200 mg twice daily) can be considered. Aplenzin 174 mg and 348 mg tablets equal 150 mg and 300 mg of bupropion hydrochloride. For smoking cessation, the generic bupropion SR label starts at 150 mg a day for 3 days, then 150 mg twice daily, never more than 300 mg a day. Lower doses are used with moderate to severe liver impairment (Wellbutrin XL: 150 mg every other day at most) and may be needed with kidney impairment.
2. Higher studied dose
Seizure risk is dose-related. The current Wellbutrin XL label gives 300 mg once daily as the usual target dose (section 2.2, Dosage for Major Depressive Disorder). Its seizure section (5.3, Seizure, under Warnings and Precautions) says "The dose should not exceed 300 mg once daily", and later in the same section says the risk of seizure can be reduced if the dose does not exceed 450 mg once daily and the dose is raised gradually; the label's highlights say the risk can be minimized by limiting the daily dose to 450 mg. Section 5.3 also says immediate-release data show seizure incidence rising almost tenfold between 450 and 600 mg a day. Forfivo XL is a single 450 mg tablet that the label says is not used to start treatment. For smoking cessation the maximum is 300 mg a day.
3. Timing
Wellbutrin XL in the morning. Twice-daily SR doses at least 8 hours apart. For smoking cessation, the label starts treatment while still smoking and sets a quit date within the first 2 weeks
4. With food
The labels say bupropion can be taken with or without food.
5. Split dosing
Extended-release and sustained-release tablets must be swallowed whole, not crushed, divided or chewed, which can raise the risk of seizures
6. How long to try
Your prescriber decides. For seasonal affective disorder, the label starts treatment in autumn, continues through winter and tapers in early spring. For smoking cessation, treatment usually lasts 7 to 12 weeks. When stopping Wellbutrin XL 300 mg, the label lowers the dose to 150 mg first. At least 14 days must pass between an MAO inhibitor and bupropion in either direction.

What to track

New or worse depression, agitation, unusual behavior or suicidal thoughts, especially in the first months, after dose changes and during a quit-smoking attempt (contact your provider right away)
Seizures, or anything that raises seizure risk, such as heavy drinking, a binge or a sudden stop of alcohol or sedatives (seek urgent care for a seizure)
Blood pressure, which the label says should be checked before and during treatment, especially with nicotine patches
Trouble sleeping, dry mouth, nausea, headache or tremor
Rash, hives, swelling or shortness of breath, which can signal an allergic reaction
Eye pain or vision changes, which can signal angle-closure glaucoma

Bottom line: Your prescriber sets the dose; swallow the tablets whole, keep alcohol to a minimum or avoid it, and never take two bupropion products together.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Dry mouth, nausea, abdominal pain and loss of appetiteTrouble sleeping, agitation, anxiety and tremorDizziness, headache, ringing in the ears and sore throatSweating, palpitations, muscle aches and rashUrinary frequency

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Wellbutrin XL label says studies of women exposed to bupropion in the first trimester (675 exposures in an international registry and 1,213 in a US insurance database) have not shown a higher risk of birth defects overall. Findings on two specific heart defects (left ventricular outflow tract obstruction and ventricular septal defect) were inconsistent and do not allow conclusions. Women who stop antidepressants during pregnancy are more likely to relapse, so the risks of untreated depression also count. A national pregnancy registry for antidepressants collects outcomes. Breastfeeding: bupropion and its active metabolites pass into breast milk; in a study of 10 women, infant exposure averaged 2% of the mother's weight-adjusted dose. There are postmarketing reports of seizures in breastfed infants, with an unclear link to bupropion. The label says to weigh the benefits of breastfeeding against the mother's need for the medicine.

Interactions

MAO inhibitors (such as phenelzine, tranylcypromine, linezolid, intravenous methylene blue)Critical

Contraindicated because of an increased risk of hypertensive reactions (dangerous blood pressure rises). The label requires at least 14 days between stopping an MAOI and starting bupropion, and at least 14 days after stopping bupropion before starting an MAOI antidepressant.

AlcoholCritical

Bupropion can cause seizures, and the label lists excessive alcohol use as a seizure risk factor and contraindicates bupropion in people who are abruptly stopping alcohol. It also reports rare cases of neuropsychiatric events or reduced alcohol tolerance in people who drank during treatment, and says alcohol should be minimized or avoided. If you usually drink a lot, do not stop drinking suddenly on your own; talk to your prescriber first.

Drugs that lower the seizure threshold (other bupropion products, antipsychotics, antidepressants, theophylline, systemic corticosteroids)High

The label says to use extreme caution, with low starting doses and gradual increases, because these drugs add to bupropion's seizure risk. Never take two bupropion products at once, such as one prescribed for depression and one for smoking.

Drugs cleared by CYP2D6 (such as nortriptyline, desipramine, venlafaxine, paroxetine, metoprolol, haloperidol, risperidone, flecainide) and tamoxifenHigh

Bupropion and its metabolites block CYP2D6. In a label study, bupropion raised desipramine exposure about 5-fold, an effect that lasted at least 7 days after the last bupropion dose. The label says doses of such drugs may need lowering, and that tamoxifen, which needs CYP2D6 to work, could in theory be less effective. Make sure each prescriber knows all your medicines.

St. John's wort (Hypericum perforatum)Moderate

In 18 healthy Chinese men given a single bupropion dose, 14 days of St. John's wort (325 mg three times daily) increased bupropion clearance from 108.3 to 130.0 liters per hour and lowered bupropion exposure, which could weaken its effect. A published case report describes facial dystonia (abnormal muscle movements) lasting about 5 months in a 58-year-old woman who had taken St. John's wort for years and started bupropion 150 mg a day to quit smoking; the authors could only propose a mechanism. Avoid combining them unless your prescriber advises it, and do not start or stop either one on your own.

Nicotine replacement (patch, gum, lozenge, inhaler, nasal spray)Moderate

This combination is often prescribed on purpose to help people quit smoking. In a trial in the label, new high blood pressure occurred in 6.1% of people on sustained-release bupropion plus a nicotine patch, compared with 2.5% on bupropion, 1.6% on the patch and 3.1% on placebo, mostly in people who already had high blood pressure. The label recommends blood pressure monitoring when the two are used together; make sure your prescriber knows about every nicotine product you use.

Saffron (supplements)Low

A 2023 systematic review lists blocking the reuptake of dopamine, norepinephrine and serotonin among saffron's proposed mechanisms, mostly from laboratory and animal work. Bupropion weakly blocks dopamine and norepinephrine reuptake, so a theoretical overlap exists, but the label says it does not inhibit serotonin reuptake, so a serotonin concern fits bupropion less well than other antidepressants. No trial has tested saffron with bupropion. In a placebo-controlled trial in 160 adults already taking an antidepressant, a standardized saffron extract (14 mg twice daily) for 8 weeks improved clinician-rated depression scores, but not self-rated scores, without increasing antidepressant side effects; its abstract does not name the antidepressants taken. The only trial that names them, a 4-week pilot in 40 adults, added crocin, a saffron compound, to the SSRIs fluoxetine, sertraline or citalopram. Discuss it with your prescriber before adding saffron.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

See all 3 Bupropion interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic bupropion (immediate-release, SR or XL), Wellbutrin SR, Wellbutrin XL (150 mg and 300 mg), Aplenzin (174, 348 and 522 mg bupropion hydrobromide) or Forfivo XL (450 mg), dispensed on your own prescription
Check the label for the form (SR or XL) and the use: only bupropion SR products are labeled for smoking cessation
A Medication Guide with each fill, which explains the suicidality and seizure warnings
Extended-release tablets must be swallowed whole; the empty tablet shell of some XL tablets can appear in the stool

Be skeptical of…

Mood or energy supplements containing St. John's wort presented as safe with bupropion
Products promising weight loss or a stimulant effect from bupropion, or sellers offering it without a prescription
Advice to crush, chew or snort tablets, which the label links to seizures and deaths
Advice to take a smoking-cessation bupropion product together with a depression bupropion product

Frequently asked questions

Can I take St. John's wort with bupropion?⌄

This page rates the pair moderate and advises against combining them without your prescriber. In a study of healthy men, St. John's wort sped up the clearance of bupropion and lowered its levels, which could weaken it, and a case report describes abnormal facial movements with the combination. Talk to your prescriber before using it.

Can I take saffron supplements with bupropion?⌄

The concern is theoretical and fits bupropion less well, because the label says bupropion does not inhibit serotonin reuptake. No trial has tested saffron with bupropion. One trial added a saffron extract to unnamed antidepressants and found antidepressant side effects did not get worse; a small pilot added a saffron compound, crocin, to the SSRIs fluoxetine, sertraline or citalopram, and its abstract does not report side-effect results. This page rates the pair low severity. Ask your prescriber before starting it.

Can I drink alcohol while taking bupropion?⌄

The Wellbutrin XL label says alcohol use should be minimized or avoided, citing rare reports of neuropsychiatric events or reduced alcohol tolerance. Heavy drinking raises seizure risk, and suddenly stopping heavy drinking while on bupropion is contraindicated. Talk to your prescriber about your drinking before starting.

Is Wellbutrin the same as the bupropion used to quit smoking?⌄

Both contain bupropion. Wellbutrin SR and XL are labeled for depression, not for quitting smoking. Their labels say they contain the same active ingredient as Zyban, which is approved to help people quit; generic bupropion SR tablets labeled for smoking cessation are also available. The labels warn not to take two bupropion products together, because that raises the seizure risk.

Can bupropion cause seizures?⌄

Yes, and the risk rises with dose. With bupropion SR up to 300 mg a day, about 1 in 1,000 people had a seizure in studies. The label lists factors that raise the risk, including eating disorders, other medicines that lower the seizure threshold, heavy alcohol use and sudden stopping of alcohol or sedatives. Your prescriber increases the dose gradually to lower the risk.

References by claim

major depressive disorder in adults

Cipriani et al., 2018 · PMC (2018) link

prevention of seasonal affective disorder (autumn-winter depression)

Modell et al., 2005 · PubMed (2005) link

smoking cessation

Hajizadeh et al., 2023 · PMC (2023) link

smoking cessation in people with and without psychiatric disorders

Anthenelli et al., 2016 · PubMed (2016) link

Safety

Wellbutrin XL (bupropion hydrochloride extended-release) prescribing information · DailyMed (FDA label) link

Bupropion hydrochloride extended-release tablets (SR) for smoking cessation, prescribing information · DailyMed (FDA label) link

Interaction: St. John's wort (Hypericum perforatum)

Lei et al., 2010 · PubMed (2010) link

Milton et al., 2007 · PMC (2007) link

Interaction: Saffron (supplements)

Lopresti et al., 2019 · PubMed (2019) link

Talaei et al., 2015 · PubMed (2015) link

Matraszek-Gawron et al., 2022 · PMC (2022) link

Interaction: Nicotine replacement (patch, gum, lozenge, inhaler, nasal spray)

Jorenby et al., 1999 · PubMed (1999) link

Track Bupropion with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.